Endocrinology
HBM contact: Dr Matthias Fehr, Dr Asun Monfort
Company status: private
VISEN Pharmaceuticals, formed by Ascendis Pharma in 2018, is committed to the treatment of endocrine-related diseases, introducing the world’s leading treatment methods and drugs into the China market.